Mindmed to participate in the leerink partners 2024 global biopharma conference

New york--(business wire)---- $mnmd--mind medicine (mindmed) inc. (nasdaq: mnmd) (cboe canada: mmed) (the “company” or “mindmed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the company's management team will host one on one investor meetings at the leerink partners 2024 global biopharma conference, which will be held in miami, fl from march 11-13, 2024. about mindmed mindmed is a clinical stage biopharma.
MNMD Ratings Summary
MNMD Quant Ranking